Literature DB >> 7829015

Prevention of biliary stent occlusion using cyclical antibiotics and ursodeoxycholic acid.

S Ghosh1, K R Palmer.   

Abstract

This study reports an open randomised controlled trial of cyclical antibiotics and ursodeoxycholic acid in prevention of plastic biliary stent occlusion. Seventy patients with malignant distal bile duct obstruction were randomised to either active treatment with cyclical antibiotics (ampicillin, metronidazole, ciprofloxacin) and ursodeoxycholic acid or no treatment after successful stent insertion. The two groups were well matched. The follow up was complete with stent occlusion or death being the end points. There was no difference in the incidence of stent occlusion between the two groups and the overall survival was similar. In conclusion, this study did not show any benefit of treatment with antibiotics and ursodeoxycholic acid in prolonging stent patency or improving survival.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7829015      PMCID: PMC1375266          DOI: 10.1136/gut.35.12.1757

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  11 in total

1.  Factors affecting the patency of stents in malignant biliary obstructive disease: univariate and multivariate analysis.

Authors:  Y Matsuda; K Shimakura; T Akamatsu
Journal:  Am J Gastroenterol       Date:  1991-07       Impact factor: 10.864

2.  Biliary stent blockage with bacterial biofilm. A light and electron microscopy study.

Authors:  A G Speer; P B Cotton; J Rode; A M Seddon; C R Neal; J Holton; J W Costerton
Journal:  Ann Intern Med       Date:  1988-04       Impact factor: 25.391

3.  Endoscopic management of malignant biliary obstruction: stents of 10 French gauge are preferable to stents of 8 French gauge.

Authors:  A G Speer; P B Cotton; K D MacRae
Journal:  Gastrointest Endosc       Date:  1988 Sep-Oct       Impact factor: 9.427

Review 4.  Bacterial biofilms in nature and disease.

Authors:  J W Costerton; K J Cheng; G G Geesey; T I Ladd; J C Nickel; M Dasgupta; T J Marrie
Journal:  Annu Rev Microbiol       Date:  1987       Impact factor: 15.500

5.  The role of bacteria in the blockage of biliary stents.

Authors:  J W Leung; T K Ling; J L Kung; J Vallance-Owen
Journal:  Gastrointest Endosc       Date:  1988 Jan-Feb       Impact factor: 9.427

6.  Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid.

Authors:  R P Jazrawi; J S de Caestecker; P M Goggin; A J Britten; A E Joseph; J D Maxwell; T C Northfield
Journal:  Gastroenterology       Date:  1994-01       Impact factor: 22.682

Review 7.  Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

8.  Optimal timing for stent replacement in malignant biliary tract obstruction.

Authors:  J T Frakes; J F Johanson; J J Stake
Journal:  Gastrointest Endosc       Date:  1993 Mar-Apr       Impact factor: 9.427

Review 9.  Ursodeoxycholic acid in chronic liver disease.

Authors:  J S de Caestecker; R P Jazrawi; M L Petroni; T C Northfield
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

10.  A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct.

Authors:  K Knyrim; H J Wagner; J Pausch; N Vakil
Journal:  Endoscopy       Date:  1993-03       Impact factor: 10.093

View more
  8 in total

1.  Prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin: a multicenter randomized trial.

Authors:  V De Lédinghen; B Person; J L Legoux; A Le Sidaner; B Desaint; M Greef; C Moesch; G Grollier; P Ingrand; D Sautereau; M Beauchant
Journal:  Dig Dis Sci       Date:  2000-01       Impact factor: 3.199

Review 2.  Plastic biliary stent occlusion: factors involved and possible preventive approaches.

Authors:  Gianfranco Donelli; Emilio Guaglianone; Roberta Di Rosa; Fausto Fiocca; Antonio Basoli
Journal:  Clin Med Res       Date:  2007-03

Review 3.  Antireflux biliary stents: are they the solution to stent occlusions?

Authors:  D Nageshwar Reddy; Rupa Banerjee; Ong Wai Choung
Journal:  Curr Gastroenterol Rep       Date:  2006-04

Review 4.  [1997 gastroenterology update--II].

Authors:  W Fischbach; V Gross; J Schölmerich; C Ell; P Layer; W E Fleig
Journal:  Med Klin (Munich)       Date:  1998-03-15

5.  A comparative evaluation of early stent occlusion among biliary conventional versus wing stents.

Authors:  Mouen A Khashab; Susan Hutfless; Katherine Kim; Anne Marie Lennon; Marcia I Canto; Sanjay B Jagannath; Patrick I Okolo; Eun Ji Shin; Vikesh K Singh
Journal:  Dig Dis Sci       Date:  2012-01-20       Impact factor: 3.199

Review 6.  Advancements in Endoscopic Biliary Interventions by Gastroenterology.

Authors:  Aymen Almuhaidb; Dylan Olson; A Aziz Aadam
Journal:  Semin Intervent Radiol       Date:  2021-08-10       Impact factor: 1.780

7.  Impact of biliary stent-related events in patients diagnosed with advanced pancreatobiliary tumours receiving palliative chemotherapy.

Authors:  Angela Lamarca; Christina Rigby; Mairéad G McNamara; Richard A Hubner; Juan W Valle
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

Review 8.  Ursodeoxycholic acid and/or antibiotics for prevention of biliary stent occlusion.

Authors:  D Galandi; G Schwarzer; D Bassler; H P Allgaier
Journal:  Cochrane Database Syst Rev       Date:  2002
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.